顯影劑市場規模、佔有率及成長分析（按類型、形式、方式、給藥途徑、適應症、應用、最終用戶和地區）－2025 年至 2032 年產業預測

2023 年顯影劑市場規模價值 69 億美元，預計將從 2024 年的 74.6 億美元成長到 2032 年的 139.1 億美元，預測期間（2025-2032 年）的複合年成長率為 8.1%。

目前，顯影劑市場受到慢性病盛行率上升、影像技術進步以及診斷影像程序增加的影響。然而，安全性問題（尤其是過敏反應）以及顯影劑的高成本阻礙了其發展，並可能限制其在發展中地區的應用。儘管面臨這些挑戰，但在顯影劑加強以及新興市場擴張的推動下，市場預計將穩定成長。這些趨勢為相關人員提供了利用進步、滿足不斷成長的需求、同時解決安全性和可負擔性問題的機會。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術分析

顯影劑市場規模（按類型）

• 市場概覽
• 碘化顯影劑
• 钆基顯影劑
• 微氣泡顯影劑
• 鋇基顯影劑

顯影劑市場規模（按類型）

• 市場概覽
• 液體
• 粉末
• 其他格式

對比顯影劑市場規模（按方式）

• 市場概覽
• X光
• 電腦斷層掃描（CT）
• 磁振造影（MRI）
• 超音波

按給藥途徑分類的顯影劑市場規模

• 市場概覽
• 血管內途徑
• 口服途徑
• 直腸途徑
• 其他給藥途徑

顯影劑市場規模（依適應症分類）

• 市場概覽
• 心血管疾病
• 癌症
• 胃腸道疾病
• 肌肉骨骼疾病
• 神經系統疾病
• 腎臟疾病

顯影劑市場規模（按應用）

• 市場概覽
• 放射學
• 介入放射學
• 介入性心臟病學

顯影劑市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Bayer AG（Germany）
• GE Healthcare（USA）
• Bracco Imaging SpA（Italy）
• Guerbet（France）
• Lantheus Holdings, Inc.（USA）
• Merck KGaA（Germany）
• FUJIFILM Corporation（Japan）
• Taejoon Pharm Co., Ltd.（South Korea）
• Beijing Beilu Pharmaceutical Co., Ltd.（China）
• Nano Therapeutics Pvt. Ltd.（India）
• CMC Contrast AB（Sweden）
• Imax Diagnostic Imaging（Canada）
• Trivitron Healthcare（India）
• Fresenius Kabi（Germany）
• Sanochemia Pharmazeutika AG（Austria）
• JB Chemicals & Pharmaceuticals Ltd.（India）
• Jodas Expoim Pvt. Ltd.（India）
• Livealth Biopharma（China）
• Spago Nanomedical AB（Sweden）
• Subhra Pharma Pvt. Ltd.（India）

結論和建議

Contrast Media Market size was valued at USD 6.9 billion in 2023 and is poised to grow from USD 7.46 billion in 2024 to USD 13.91 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The contrast media market is currently influenced by a rising prevalence of chronic diseases, advances in imaging technologies, and an increase in diagnostic imaging procedures. However, growth is hindered by safety concerns, particularly regarding allergic reactions, and the high costs associated with contrast agents, which can limit adoption in developing regions. Despite these challenges, the market is expected to experience steady growth driven by innovations in contrast agent development, enhanced technological integration, and expanding markets. These trends present opportunities for stakeholders to capitalize on advancements and cater to growing demand while addressing safety and affordability issues.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contrast Media market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contrast Media Market Segments Analysis

Global Contrast Media Market is segmented by Type, Form, Modality, Route of Administration, Indication, Application and region. Based on Type, the market is segmented into Iodinated contrast media, Gadolinium-based contrast media, Microbubble contrast media and Barium-based contrast media. Based on Form, the market is segmented into Liquid, Powder and Other forms. Based on Modality, the market is segmented into X-ray, Computed tomography (CT), Magnetic resonance imaging (MRI) and Ultrasound. Based on Route of Administration, the market is segmented into Intravascular route, Oral route, Rectal route and Other routes of administration. Based on Indication, the market is segmented into Cardiovascular disease, Cancer, Gastrointestinal disorders, Musculoskeletal disorders, Neurological disorders and Nephrological disorders. Based on Application, the market is segmented into Radiology, Interventional radiology, Interventional cardiology. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contrast Media Market

The Contrast Media market is primarily driven by an increasing awareness among patients about the critical role of diagnostic imaging in managing and detecting diseases, leading to a heightened demand for contrast agents. Additionally, the advocacy from healthcare professionals significantly contributes to market growth, as medical practitioners are increasingly acknowledging the value and benefits of contrast-enhanced imaging in achieving accurate diagnoses and outcomes. This recognition has translated into a surge in the number of prescriptions for these agents, further fuelling the expansion of the Contrast Media market as both patients and providers seek to enhance diagnostic effectiveness.

Restraints in the Contrast Media Market

The growth of the Contrast Media market is significantly hindered in many developing regions due to a limited number of healthcare professionals and inadequate access to advanced technologies and facilities. Furthermore, the lack of awareness about the benefits and applications of contrast media can impede market expansion. Additionally, insufficient training for medical practitioners regarding the use of contrast agents and their associated imaging techniques further restricts adoption. These factors collectively contribute to a challenging environment for the growth of the contrast media market, as they prevent effective utilization and understanding of these critical imaging tools within the healthcare sector.

Market Trends of the Contrast Media Market

The Contrast Media market is witnessing a significant trend towards improved safety profiles, driven by advancements in gadolinium-based contrast agents. Research focusing on minimizing nephrogenic systemic fibrosis (NSF) risks has led to the development of novel agents that emphasize reduced gadolinium retention. This shift is pushing healthcare providers to favor agents with enhanced safety features, which are particularly beneficial for patients with compromised renal function. Additionally, the adoption of non-ionic low osmolar contrast agents in computed tomography is gaining traction, as they effectively minimize side effects. This evolving landscape highlights a growing preference for safer, more effective contrast media solutions among healthcare professionals.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis

Global Contrast Media Market Size by Type & CAGR (2025-2032)

• Market Overview
• Iodinated contrast media
• Gadolinium-based contrast media
• Microbubble contrast media
• Barium-based contrast media

Global Contrast Media Market Size by Form & CAGR (2025-2032)

• Market Overview
• Liquid
• Powder
• Other forms

Global Contrast Media Market Size by Modality & CAGR (2025-2032)

• Market Overview
• X-ray
• Computed tomography (CT)
• Magnetic resonance imaging (MRI)
• Ultrasound

Global Contrast Media Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Intravascular route
• Oral route
• Rectal route
• Other routes of administration

Global Contrast Media Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Cardiovascular disease
• Cancer
• Gastrointestinal disorders
• Musculoskeletal disorders
• Neurological disorders
• Nephrological disorders

Global Contrast Media Market Size by Application & CAGR (2025-2032)

• Market Overview
• Radiology
• Interventional radiology
• Interventional cardiology

Global Contrast Media Market Size & CAGR (2025-2032)

• North America (Type, Form, Modality, Route of Administration, Indication, Application)
  • US
  • Canada
• Europe (Type, Form, Modality, Route of Administration, Indication, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Form, Modality, Route of Administration, Indication, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Form, Modality, Route of Administration, Indication, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Form, Modality, Route of Administration, Indication, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guerbet (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taejoon Pharm Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing Beilu Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nano Therapeutics Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CMC Contrast AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imax Diagnostic Imaging (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trivitron Healthcare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanochemia Pharmazeutika AG (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J.B. Chemicals & Pharmaceuticals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jodas Expoim Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Livealth Biopharma (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spago Nanomedical AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Subhra Pharma Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations